Breast Cancer Clinical Trial
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction
The researchers are doing this study to look at the number of complications that occur immediately after prepectoral breast reconstruction when Acellular Dermal Matrix (ADM) is used compared to when ADM is not used. These complications include infections, the need for Tissue Expander (TE) or implant removal, and other conditions that lead to additional surgery.
Females aged 21-60 years
Planning to undergo unilateral or bilateral mastectomy, prophylactically or to treat breast cancer
Planning to undergo immediate two-stage prosthetic breast reconstruction with TE placement as the first stage
Planning to undergo nipple-sparing or skin-sparing mastectomy
Adequate mastectomy skin perfusion or adequate perfusion but nonviable mastectomy skin that can be excised (≤4 cm) at the defect margins with otherwise adequate perfusion
Intraoperative confirmation of prepectoral plane viability by operating physician
History of radiotherapy
Non-English speaking patients
Planning to undergo direct-to-implant reconstruction
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.